Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

Yokoda, Raquel T. MD1,2; Carey, Elizabeth J. MD1,3

American Journal of Gastroenterology: October 2019 - Volume 114 - Issue 10 - p 1593–1605
doi: 10.14309/ajg.0000000000000268

Cholestatic liver diseases encompass a broad spectrum of pathologies, with the core injury occurring at the level of cholangiocytes and progressing to hepatic fibrosis and liver dysfunction. Primary biliary cholangitis and primary sclerosing cholangitis are the most significant progressive cholangiopathies in adults. Although rare, they commonly evolve to liver failure and need for liver transplantation. Despite recent advances in the basic knowledge of these cholangiopathies, the pathogenesis is still elusive. Targeted treatments to prevent disease progression and to preclude malignancy are not yet available. This review will address the general clinical features of both diseases, analyze their commonalities and differences, and provide a state-of-the art overview of the currently available therapeutics.

1Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Scottsdale, Arizona, USA;

2Transplant Hepatology Fellow, Mayo Clinic School of Graduate Medical Education, Scottsdale, Arizona, USA;

3Transplant Center, Mayo Clinic, Phoenix, Arizona, USA.

Correspondence: Elizabeth J. Carey, MD. E-mail:

SUPPLEMENTARY MATERIAL accompanies this paper at

Received April 10, 2019

Accepted April 10, 2019

Online date: June 4, 2019

© The American College of Gastroenterology 2019. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website